Authors: Salmela, K Wramner, L Ekberg, F Hauser, I Bentdal, O Lins, LE Isoniemi, H Backman, L Persson, N Neumayer, HH Jorgensen, PF Spieker, C Hendry, B Nicholls, A Kirste, G Hasche, G

Citation: K. Salmela et al., A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation - A report of the European anti-ICAM-1 renal transplant study group, TRANSPLANT, 67(5), 1999, pp. 729-736